Novel formulation for the treatment of interstitial cystitis

Interstitial cystitis is an inflammatory disease of the urinary bladder and is recognized as a serious medical condition associated with a profoundly negative impact on patients quality of life. Currently, there are no widely acknowledged causes of this disorder and no effective treatments available. Panag is a Halifax based drug company which focuses on development of novel therapeutic treatments which can be used to alleviate both pain and inflammation associated with IC. The goal of our research is to provide IC patients with symptom and pain relief, as well as to improve outcome. Previous research showed that the immune system is regulated by another system within our body, called the endocannabinoid system. Our approach uses special drugs, called cannabinoids, which are designed to target this system and as a result, provide symptom and pain relief and improve patients quality of life. TO BE CONT’D

Faculty Supervisor:

Juan Zhou

Student:

Ian Burkovskiy

Partner:

Panag Pharma Inc

Discipline:

Medicine

Sector:

Pharmaceuticals

University:

Program: